Timothy C. Dec - 10 Mar 2025 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
Senior Vice-President & CFO
Signature
/s/ Timothy C. Dec
Issuer symbol
SUPN
Transactions as of
10 Mar 2025
Net transactions value
-$64,665
Form type
4
Filing time
11 Mar 2025, 16:15:41 UTC
Previous filing
05 Mar 2025
Next filing
26 Aug 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SUPN Common Stock Options Exercise $0 +2,000 +18% $0.000000 12,898 10 Mar 2025 Direct F1
transaction SUPN Common Stock Tax liability $34,048 -1,062 -8.2% $32.06 11,836 10 Mar 2025 Direct F2
transaction SUPN Common Stock Options Exercise $0 +1,800 +15% $0.000000 13,636 10 Mar 2025 Direct F3
transaction SUPN Common Stock Tax liability $30,617 -955 -7% $32.06 12,681 10 Mar 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Performance Share Unit Options Exercise $0 -2,000 -100% $0.000000 0 10 Mar 2025 Common Stock 2,000 $0.000000 Direct F4
transaction SUPN Performance Share Unit Options Exercise $0 -1,800 -100% $0.000000 0 10 Mar 2025 Common Stock 1,800 $0.000000 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 23, 2023.
F2 Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units.
F3 Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 22, 2024.
F4 On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023.
F5 On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024.